Ion Exchange share price: key levels and FY2026 metrics

Stock snapshot and why it is in focus

Ion Exchange (India) Ltd (NSE: IONEXCHANG, BSE: 500214) is being tracked after a mix of price volatility, weak one-year returns, and fresh financial updates showing margin pressure. The stock is part of the capital goods space, with industry tagging seen as engineering - industrial equipments, while another classification in the provided data lists the sector as Environmental Services.

The price data points shared show multiple snapshots across dates and sources. One quote places the stock at ₹402.70, up ₹6.40 (1.61%) on the BSE (timestamped “Today, 04:01 PM”). Another snapshot says the share price of IONEXCHANG on 9 July 2026 is ₹407.10. A separate update notes the stock at ₹387.65 as on 18 May 2026, down 0.65% from ₹390.15.

How far is the stock from its 52-week high

The dataset explicitly notes the price is 31.64% away from the 52-week high. The widely repeated 52-week range in the text is:

• 52-week high: ₹580.75 (also shown as ₹580.65 in one line)
• 52-week low: ₹312.70 (also shown as ₹312.3 / ₹312.7 in some places)

For the “today” trading range, one quote lists:

• Today’s high: ₹408.95
• Today’s low: ₹397.8

And another section lists:

• Day’s high: ₹409.10
• Day’s low: ₹397.65

The text also contains a separate table with a different 52-week high and low (52 Week High on 11-Dec-2024 at 744.20 and 52 Week Low on 15-Oct-2025 at 384.50). Because the article data contains multiple ranges from different contexts, readers should rely on the range that matches their platform and the stated “as of” date.

Seasonal pattern: July has been positive in 3 of 5 years

A seasonal statistic included in the data says Ion Exchange (India) has delivered positive returns in July in 3 out of the past 5 years. This is not a forecast, but a backward-looking pattern that some short-term traders track alongside fundamentals and liquidity.

Historical returns: strong five-year, weak one-year

The provided historical performance numbers show a sharp divergence by time period. One set of returns states:

• 1 month: +14.46%
• 3 months: +7.12%
• 1 year: -26.84%
• 3 years: -22.69%
• 5 years: +112.34%

Another list (also included in the text) reports:

• Past 1 week: -3.77%
• Past 1 month: +14.34%
• Past 3 months: +8.04%
• Past 6 months: +7.88%
• Past 1 year: -26.96%
• Past 3 years: -18.51%
• Past 5 years: +112.34%

Across both sets, the five-year return is consistently shown as +112.34%, while the one-year return is around -27%. That combination suggests the stock has rewarded long-horizon holders in the past but has faced a significant drawdown more recently.

Q4 profit update: sharp year-on-year decline, sequential recovery

The data states Ion Exchange (India) Ltd’s net profit fell 61.89% year-on-year to ₹24.14 crore in Q4 2025-2026. At the same time, it also reports an 18.92% jump in net profit on a quarterly growth basis versus the prior three months.

This combination points to a tough year-on-year base comparison while indicating some sequential improvement in the most recent quarter. The same broader context in the text also mentions margin pressure as a theme in the latest results.

FY2026 operating income and EBITDA: growth with margin pressure

A detailed performance note in the provided data says the company saw “resilient top-line growth but marked margin pressure,” with FY2026 operating income at INR 29,148 million and EBITDA falling about 29% to INR 2,102 million.

Normalized to a single unit (INR crore):

• FY2026 operating income: ₹2,914.8 crore
• FY2026 EBITDA: ₹210.2 crore (down about 29%)

This is important for investors because operating income and EBITDA trends can diverge when input costs rise, logistics and execution issues delay deliveries, or depreciation and interest costs rise after commissioning capacity.

What management flagged: Roha, membranes, and international projects

The same note outlines management priorities and near-term headwinds. Strategic priorities highlighted include scaling newly commissioned capacity at Roha, expanding membrane capabilities via the MANN+HUMMEL collaboration, and growing international projects including Oman (DBOOT) and a Malawi award to broaden recurring revenues.

Management also flagged near-term challenges, including West Asia logistics disruptions and raw-material inflation. The note says these factors deferred GCC dispatches, reduced engineering margins, dented March chemical profitability, and that higher interest and depreciation from Roha weighed on results.

Actions mentioned as underway include pricing pass-throughs, focusing on utilisation of installed capacity before major new capital spending, and targeted investments in the consumer business to drive volume and move toward break-even.

Contract-related triggers seen in the headlines

The dataset includes headline snippets pointing to contract activity. It references Ion Exchange’s arm securing a contract from Petroleum Development Oman (timestamps shown on 11 Feb) and other mentions of securing contracts from Rayzon Energy and INOX Solar.

While these items can act as sentiment triggers, the market reaction typically depends on contract size, margin profile, execution timelines, and working capital intensity, none of which are quantified in the provided text.

Profitability ratios: ROE and ROCE context

One line in the data reports ROE at 16.26%. A separate analysis note states Ion Exchange (India) has an ROCE of 19%, compared with an industry average of 17% (Commercial Services industry reference as written). It also says returns on capital were around 32% about five years ago, and have since fallen to 19%.

The same note adds that current liabilities have decreased to 50% of total assets, suggesting the company is funding more of its operations with its own capital rather than relying as much on suppliers or short-term creditors. That change can reduce certain risks but can also lower measured capital efficiency.

Key numbers table

Market impact and what investors are watching

From the price and returns data, the near-term picture is mixed: recent months show positive returns, while the one-year return remains deeply negative. The 31.64% gap from the 52-week high frames how much the stock has to recover to retest prior peaks.

On fundamentals, the tension is between revenue growth signals and profitability pressure. The FY2026 figures in the provided note show operating income at ₹2,914.8 crore while EBITDA fell to ₹210.2 crore, indicating cost and execution factors are playing a bigger role than topline alone. The Q4 snapshot adds that profit fell sharply year-on-year, even as it improved sequentially.

Conclusion

Ion Exchange (India) is navigating a phase where topline growth and project momentum are being weighed against margin pressure and a steep year-on-year profit drop in Q4 2025-2026. Near-term attention is likely to stay on execution at Roha, the impact of logistics and input costs on dispatches and margins, and how quickly profitability stabilises alongside any new contract updates.